Live Breaking News & Updates on Rodd Leeds David Waldman

Stay updated with breaking news from Rodd leeds david waldman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Scopus BioPharma's Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer

NEW YORK, Nov. 10, 2022 Scopus BioPharma Inc. , a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, and its pure-play. | November 10, 2022 ....

United States , Rodd Leeds David Waldman , Scopus Biopharma , Exchange Commission , Company Form , Scopus Biopharma Inc , Boston Convention , Crescendo Communications , Exhibition Center , Annual Meeting , Scopus Biopharma Inc Stock Exchange , Press Release , Ts Scps Us8091711015 ,

Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value

18.10.2022 - Warrants to Purchase Approximately 21 Million Scopus Shares Eliminated Scopus BioPharma’s Pure Play Immuno-Oncology Subsidiary, Duet BioTherapeutics, Independently Valued at $25 Million Scopus Maintains Approximately 90% Ownership Stake in Duet . ....

Marcin Kortylewski , Rodd Leeds David Waldman , Scopus Biopharma , Joshuar Lamstein , Alan Horsager , Exchange Commission , Company Form , Scopus Biopharma Inc Nasdaq , Scopus Biopharma Inc , Crescendo Communications , Duet Being Positioned , Biopharma Inc , Chief Executive Officer , Senior Scientific Advisor ,

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors - read this article along with other careers information, tips and advice on BioSpace ....

United States , Israel General , Celgene Bristol Myers Squibb , Rodd Leeds David Waldman , Scopus Biopharma , Joshuar Lamstein , Raphael Rafi Hofstein , Alan Horsager , Zealand Pharma , Department Of Neurobiology At Harvard Medical School , Scopus Biopharma Inc , Crescendo Communications , Weizmann Institute Of Science , Exchange Commission , Company Form , Delaware Court , Hebrew University Of Jerusalem , Life Sciences , Corporation Law , Fibrocor Therapeutics , Encycle Therapeutics , Bristol Myers Squibb , Hebrew University , Weizmann Institute , Harvard Medical , Duet Platform ,

Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , Rodd Leeds David Waldman , Scopus Biopharma , Alan Horsager , Company Form , Exchange Commission , Scopus Biopharma Inc , Crescendo Communications , Chief Executive Officer , Bifunctional Approach , Targeting Therapies Summit , Novel Methods , Duet Platform , Biopharma Inc , Globe Newswire ,

Scopus BioPharma's Subsidiary — Duet BioTherapeutics — to

Alan Horsager, Ph.D., President and Chief Executive Officer of Duet, to Present onTLR9 Activation and STAT3 Inhibition: A Bifunctional Approach to. ....

United States , Rodd Leeds David Waldman , Scopus Biopharma , Alan Horsager , Company Form , Exchange Commission , Scopus Biopharma Inc , Crescendo Communications , Chief Executive Officer , Bifunctional Approach , Targeting Therapies Summit , Novel Methods , Duet Platform , Biopharma Inc , Nasdaq Scps , Scopus Biopharma Inc ,